(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

C

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

C

ST13

US500000078161125

Class

5

Filing

78161125

Registration

2833222

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

06/29/2024

Trademark type

Combined

Nice classes

5

Filing date

09/05/2002

Registration date

04/13/2004

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/29/2024

Last transaction

06/29/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/26/2003

First use in commerce

11/26/2003

Drawing code

3

Owner type

03

Owner location

Indianapolis, IN, US

Examiner

NEVILLE, BRIAN

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a gold colored, ovoid shaped tablet bearing a stylized letter "C".

Holders and representatives

Holders

Eli Lilly and Company
Lilly ICOS L.L.C.

Representatives

Bruce W. Longbottom

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and medicinal preparations for treatment of sexual dysfunction; pharmaceutical and medicinal preparations for prevention of sexual dysfunction

Publications

History of USPTO decisions and trademark events.

38 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/29/2024

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

06/29/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/29/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/29/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

04/01/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

04/13/2023

NOSU

NOTICE OF SUIT

04/20/2018

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

12/07/2013

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

12/07/2013

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

12/07/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/06/2013

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

11/19/2013

E89R

TEAS SECTION 8 & 9 RECEIVED

11/19/2013

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/19/2013

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

04/21/2010

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/21/2010

E815

TEAS SECTION 8 & 15 RECEIVED

04/08/2010

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

01/16/2008

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

08/04/2006

PLGL

ASSIGNED TO PARALEGAL

07/25/2006

AMD7

SEC 7 REQUEST FILED

06/21/2006

MAIL

PAPER RECEIVED

06/21/2006

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/23/2006

R.PR

REGISTERED-PRINCIPAL REGISTER

04/13/2004

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

02/04/2004

CFIT

CASE FILE IN TICRS

01/30/2004

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/08/2004

EX1G

SOU EXTENSION 1 GRANTED

01/08/2004

IUAF

USE AMENDMENT FILED

12/16/2003

EXT1

SOU EXTENSION 1 FILED

12/16/2003

EISU

TEAS STATEMENT OF USE RECEIVED

12/16/2003

EEXT

SOU TEAS EXTENSION RECEIVED

12/16/2003

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

07/08/2003

PUBO

PUBLISHED FOR OPPOSITION

04/15/2003

NPUB

NOTICE OF PUBLICATION

03/26/2003

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/24/2003

DOCK

ASSIGNED TO EXAMINER

02/19/2003

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

09/24/2002

Continuous trademark protection

Get notified about every new filing that threatens C or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.